NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Suven Pharmaceuticals Limited (NSE: SUVENPHAR)
SUVENPHAR Technical Analysis
3
As on 19th Mar 2025 SUVENPHAR SHARE Price closed @ 1159.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1016.44 & Buy for SHORT-TERM with Stoploss of 1111.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SUVENPHARSHARE Price
Open | 1133.75 | Change | Price | % |
High | 1175.00 | 1 Day | 25.50 | 2.25 |
Low | 1102.25 | 1 Week | 1.30 | 0.11 |
Close | 1159.25 | 1 Month | -0.70 | -0.06 |
Volume | 479237 | 1 Year | 548.80 | 89.90 |
52 Week High 1000.65 | 52 Week Low 464.90 |
NSE INDIA Most Active Stocks
IDEA | 7.44 | 4.79% |
EASEMYTRIP | 13.16 | 2.33% |
JPPOWER | 14.75 | 10.24% |
YESBANK | 17.03 | 3.59% |
SUZLON | 57.76 | 5.06% |
GTLINFRA | 1.53 | 3.38% |
TATASTEEL | 158.60 | 2.55% |
ZOMATO | 223.53 | 2.45% |
SAIL | 113.23 | 3.97% |
RPOWER | 37.72 | 8.39% |
NSE INDIA Top Gainers Stocks
GRSE | 1641.35 | 20.00% |
VSTL | 155.83 | 20.00% |
KSOLVES | 410.55 | 19.99% |
ASIANENE | 287.41 | 19.39% |
SINDHUTRAD | 19.08 | 19.32% |
TANLA | 520.60 | 17.54% |
DOLATALGO | 85.96 | 17.03% |
BROOKS | 118.50 | 16.30% |
MANAKSTEEL | 54.19 | 14.91% |
IDEAFORGE | 383.90 | 14.14% |
NSE INDIA Top Losers Stocks
SUVENPHAR Daily Charts |
SUVENPHAR Intraday Charts |
Whats New @ Bazaartrend |
SUVENPHAR Free Analysis |
|
SUVENPHAR Important Levels Intraday
RESISTANCE | 1299.44 |
RESISTANCE | 1254.48 |
RESISTANCE | 1226.69 |
RESISTANCE | 1198.90 |
SUPPORT | 1119.60 |
SUPPORT | 1091.81 |
SUPPORT | 1064.02 |
SUPPORT | 1019.06 |
SUVENPHAR Target March 2025
4th UP Target | 1609.73 |
3rd UP Target | 1431.74 |
2nd UP Target | 1321.73 |
1st UP Target | 1211.71 |
1st DOWN Target | 897.79 |
2nd DOWN Target | 787.77 |
3rd DOWN Target | 677.76 |
4th DOWN Target | 499.77 |
SUVENPHAR Weekly Target
4th UP Target | 1309.03 |
3rd UP Target | 1257.61 |
2nd UP Target | 1225.83 |
1st UP Target | 1194.04 |
1st DOWN Target | 1103.36 |
2nd DOWN Target | 1071.57 |
3rd DOWN Target | 1039.79 |
4th DOWN Target | 988.37 |
SUVENPHAR Target2025
4th UP Target | 2716.96 |
3rd UP Target | 2210.82 |
2nd UP Target | 1897.96 |
1st UP Target | 1585.11 |
1st DOWN Target | 692.4 |
2nd DOWN Target | 379.54 |
3rd DOWN Target | 66.68 |
4th DOWN Target | -439.46 |
Suven Pharmaceuticals Limited ( NSE INDIA Symbol : SUVENPHAR )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
SUVENPHAR Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | Stoploss For Long Buy | 336.14 | |
10 Day Avg Volume | N/A |
SUVENPHAR Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
SUVENPHAR Address
![]() |
SUVENPHAR Latest News
SUVENPHAR Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service